← AI, data and analytics companies

    AI Proteins: company profile, size and contacts

    aiproteins.comActiveFor profit

    AI Proteins is a biotechnology company that focuses on designing and engineering of synthetic miniprotein therapeutics.

    Employees
    11-50
    Founded
    2021
    Total raised
    $23.2M
    Region
    Greater Boston Area

    Company facts

    Website
    aiproteins.com
    Location
    Greater Boston Area, East Coast, New England, Northeastern US
    Employees
    11-50
    Founded
    2021 (5 years ago)
    Categories
    Artificial Intelligence (AI), Biotechnology, Therapeutics
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    5415 Computer systems design and related services; 5182 Computing infrastructure providers and data processing
    Industry code (SIC)
    7374 Computer processing and data preparation; 7371 Computer programming services

    Founders

    • Carl NovinaFounder · AI Proteins
    • Chris BahlFounder · AI Proteins
    • Marc CohenFounder · AI Proteins

    AI Proteins was founded in 2021 by Carl Novina, Chris Bahl, Marc Cohen.

    Funding

    Total raised
    $23.2M
    Funding rounds
    3
    Latest round
    Debt financing, 2024-03
    Investors
    3
    Lead investors
    3

    How AI Proteins compares

    • Size: AI Proteins has more employees than 19% of the 536 ai, data and analytics companies in our directory that report it.
    • Age: AI Proteins is older than 5% of the 518 ai, data and analytics companies in our directory that report it.

    545 ai, data and analytics companies are in the directory, 225 of them in the same 11-50 employee range and 11 based in Greater Boston Area.

    Growth outlook

    • Trend: Growing

    AI Proteins may be growing as evidenced by its strategic R&D collaboration with Vivtex to develop novel, oral biologic therapies for inflammatory diseases, which suggests an expansion of its research and development capabilities. This partnership could potentially lead to increased revenue streams and market presence for AI Proteins. Additionally, the company's involvement in the application of AI to facilitate protein pairing indicates an innovative approach to biotechnology, which may enhance its product offerings and competitive edge in the therapeutics industry.

    What AI Proteins says about itself

    “AI Proteins pioneers programmable miniproteins—engineered from scratch with AI, robotics, and synthetic biology to create safer, more precise biologics for patients.” aiproteins.com

    AI Proteins in short

    AI Proteins has a 11-50 person team and operates in artificial intelligence (ai), listed under Greater Boston Area, and has been around since 2021. Its founders are Carl Novina, Chris Bahl and Marc Cohen and it has raised $23.2 million over 3 rounds.

    Frequently asked questions

    What does AI Proteins do?
    AI Proteins is a biotechnology company that focuses on designing and engineering of synthetic miniprotein therapeutics.
    When was AI Proteins founded?
    AI Proteins was founded in 2021, so it is about 5 years old.
    How many employees does AI Proteins have?
    Crunchbase lists AI Proteins in the 11-50 employee range.
    Where is AI Proteins based?
    AI Proteins is listed under Greater Boston Area, East Coast, New England, Northeastern US.
    Has AI Proteins raised funding?
    Crunchbase records $23.2M raised across 3 funding rounds, most recently debt financing in 2024-03.
    How do I find email addresses at AI Proteins?
    Search the domain aiproteins.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in AI, data and analytics companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.